A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinical forms of mantle cell lymphoma. With this therapy...
Read moreIt is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer tr...
Read moreEl Dr. Benjamí Oller, investigador del Grupo de Ingeniería de Materiales – GEMAT – de IQS School of Engineering, trabaja en el desarrollo de una terapia dirigida que pueda abordar con éxito los...
Read moreThis study shows the promise of Omomyc as an anti-metastatic therapy against breast cancer and also challenges the controversial notion that MYC inhibition potentiates, rather than inhibits, tumor cel...
Read moreEntre todas las herramientas de diagnóstico para el cáncer de mama, hemos de destacar la imagen médica. Y es que, de hecho, esta es la protagonista de los programas de cribado que se utilizan en pa...
Read moreResearch led by researchers from the University of Granada (UGR), belonging to the Preventive Medicine and Public Health research group of the Granada Biosanitary Research Institute (ibs.GRANADA), has...
Read moreLos resultados de este estudio suponen una nueva propuesta terapéutica contra el glioblastoma: el uso del fármaco ADI-PEG20, que elimina la arginina sistémica, en combinación con la aplicación de...
Read moreA paper published in the journal Cell Reports describes the development of a new system based on stem cells to generate neurofibromas, tumors of the peripheral nervous system. These tumors develop in ...
Read moreIRB Barcelona is leading a project that will be done in collaboration with the Instituto de Investigación Sanitaria INCLIVA in Valencia, the University of Cantabria and the Institute of Biomedicine a...
Read moreLos resultados del estudio fase III Empower muestran un aumento de la supervivencia con el anticuerpo anti-PD-1 cemiplimab en el cáncer de cuello uterino recurrente.
Read moreUn total de 2.000 pacientes con tumores metastásicos van a tener la oportunidad de formar parte de manera gratuita del estudio DIPCAN (Digitalización y Manejo de la Medicina Personalizada en Cáncer...
Read moreSzymuś arrived at SJD Barcelona Children's Hospital from Poland when he was 2 years old. He was a normal, healthy child, full of energy, who was growing and developing just like all his friends. The ...
Read more